Does DHSEA contain within it the seeds of the industry’s downfall? The freewheeling marketplace this regulation created has placed the barriers to entry so low that less than reputable companies have room to maneuver, creating risk for the whole industry.
Are supplements getting better? It’s a bit of a tricky question when applied to probiotics, as the ingredients are relatively new to the market. There are many examples of quality improvements within this category, but it exhibits some features that are...
Results from an omega-3 study found a positive link between treatment using EPA and cardiovascular outcomes. It was backed by pharmaceutical company Amarin, which enjoyed a 300% surge in shares after the study results were announced.
Supplement critic Dr Pieter Cohen has trained his sights on probiotics for a new opinion paper, stating that the sector has spun hundreds of small studies favorably and also practices creative advertising.
Like all emerging industries, sports nutrition thrives on innovation and a degree of risk-taking that has seen the likes of ketone-based drinks, probiotics and human milk oligosaccharides (HMOs) emerge as credible mainstream products.
A new BBC article dismisses the benefits of probiotics because a study failed to find colonization. It is a serious mistake to confuse colonization with efficacy and we need to get this message across to consumers.
A recent study reported something very impressive: A decade after the end of a randomized clinical trial, the benefits of dietary supplementation not only persisted, but seemed to be getting bigger. So why are we not talking about this more?
A recent mainstream press article that calls vitamin D research into question is a low blow that hinges on an attack on a prominent researcher’s character rather than a sober assessment of the science behind the nutrient, experts say.
HerbalGram has grown into one of the world’s most influential herbal medicine journals as it celebrates its 35th anniversary. Founder Mark Blumenthal says he’s certain he made the right decision almost 30 years ago to give the publication away.
Reaction continues to roll in on the recent Cochrane review that found little evidence supporting the cardiovascular benefits of omega-3s. Experts questioned the underlying assumptions in how the review was put together.